OraLert 6 - Saliva Drug Test Kit
This is the newest and best saliva drug test on the market!
Faster, more sensitive, and easier-to-use.
Saliva collection takes only about 3 minutes. Accurate, unadulterated test results, without urine, in 10 minutes or less. No special training required.
6-Substance OraLert Oral Fluid Drug test with twist screening is a saliva drug test kit that rapidly detects the presence of:
- amphetamines
- cocaine
- opiates
- methamphetamine
- PCP
- marijuana (THC)
Cutting-edge saliva drug testing design aids in the sensitive detection of THC!
Saliva drug tests are ideal for urine-free workplace or home drug testing. Eliminate time, embarrassment, and costs involved with workplace urine drug testing and urine handling:
- No more urine!
- Observed saliva specimen collections without donor privacy issues
- Sensitive and specific assays screens more accurately than other oral fluid drug test kits
- Non-invasive
- Eliminates need for same-gender sample collection.
- No more collection site costs
- Testing integrity (difficult to adulterate)
- Allows for immediate hiring or treatment decision
- No additional equipment or operator training required
- Complete test kit includes all components for testing including an easy-to-follow procedure card to help eliminate potential procedural errors
Simultaneously screens for all DOT (US Dept of Transportation) workplace drug testing standard substances: amphetamines, cocaine, opiates, methamphetamine, PCP, and marijuana. This test is a clinical grade drug test designed for professional drug testing.
Oral Fluid Drug Screen Device for ( AMP mAMP COC OPI THC PCP ) is a lateral flow
chromatographic immunoassay for the qualitative detection of amphetamine, methamphetamine, cocaine,
opiates, marijuana, phencyclidine and their metabolites in oral fluids at the following cut-off concentrations:
| Test |
Calibrator |
Cut-off |
| Amphetamine (AMP) |
d-Amphetamine |
50 ng/mL |
| Cocaine (COC) |
Benzoylecgonine |
20 ng/mL |
| Methamphetamine (mAMP) |
d-Methamphetamine |
50 ng/mL |
| Opiates (OPI) |
Morphine |
40 ng/mL |
| Phencyclidine (PCP) |
Phencyclidine |
10 ng/mL |
| Marijuana (THC) |
Δ9-THC |
100 ng/mL |
Analytical Specificity
The following tables lists the concentration of compounds (ng/mL) that are detected positive in urine by the
One Step Drug Screen Test Card (Urine) at 5 minutes.
| AMPHETAMINE (AMP) |
| d-Amphetamine |
50 |
| d,l-Amphetamine |
125 |
| β-Phenylethylamine |
40000 |
| Tryptamine |
1500 |
| p-Hydroxyamphetamine |
800 |
| 3,4-Methylendioxyamphetamine (MDA) |
150 |
| l-Amphetamine |
4000 |
| COCAINE (COC) |
| Benzoylecgonine |
20 |
| Cocaine |
20 |
| Cocaethylene |
25 |
| Ecgonine |
1500 |
| Ecgonine methylester |
12500 |
| MARIJUANA (THC) |
| 11-nor-Δ9 -THC-9 COOH |
12 |
| Cannabinol |
3000 |
| Δ8 –THC |
100 |
| Δ9 –THC |
100 |
| METHAMPHETAMINE (mAMP) |
| d-Methamphetamine |
50 |
| p-Hydroxymethamphetamine |
400 |
| Fenfluramine |
60000 |
| Methoxyphenamine |
25000 |
| 3,4–Methylenedioxymethamphetamine (MDMA) |
50 |
| l-Phenylephrine |
4000 |
| Procaine |
2000 |
| (1R,2S) - (-) Ephedrine |
400 |
| OPIATES (OPI) |
| Morphine |
40 |
| Codeine |
10 |
| Ethylmorphine |
24 |
| Hydrocodone |
100 |
| Hydromorphone |
100 |
| Levorphanol |
400 |
| 6-Monoacetylmorphine (6-MAM) |
25 |
| Morphine 3-β-D-glucuronide |
50 |
| Norcodeine |
1500 |
| Normorphine |
12500 |
| Oxycodone |
25000 |
| Oxymorphone |
25000 |
| Diacetylmorphine (Heroin) |
50 |
| Thebaine |
1500 |
| Nalorphine |
10000 |
| PHENCYCLIDINE (PCP) |
| Phencyclidine |
10 |
| Tetrahydrozoline |
50000 |
The OrALert™ Oral Fluid Drug Screen Device for AMP/mAMP/COC/OPI/THC/PCP is a lateral flow chromatographic immunoassay for the qualitative detection of amphetamine, methamphetamine, cocaine, opiates, marijuana, phencyclidine and their metabolites in oral fluids at the following cut-off concentrations:
The OrALert™ Oral Fluid Drug Screen Device for AMP/mAMP/COC/OPI/THC/PCP is an immunoassay based on the principle of competitive binding. Drugs that may be present in the oral fluid specimen compete against their respective drug conjugates for binding sites on their specific antibody.
During testing, a portion of the oral fluid specimen migrates upward by capillary action. A drug, if present in the oral fluid specimen below its cut-off concentration, will not saturate the binding sites of its specific
antibody. The antibody will then react with the drug-protein conjugate and a visible colored line will show up in the test line region of the specific drug strip. The presence of drug above the cut-off concentration in the oral
fluid specimen will saturate all the binding sites of the antibody. Therefore, the colored line will not form in the test line region.
A drug-positive oral fluid specimen will not generate a colored line in the specific test line region of the strip because of drug competition, while a drug-negative oral fluid specimen will generate a line in the test line
region because of the absence of drug competition.
To serve as a procedural control, a colored line will always appear at the control line region, indicating that proper volume of specimen has been added and membrane wicking has occurred.
